Centro de Investigaciones y Desarrollo de Medicamentos

CIDEM is a prominent Cuban scientific institution dedicated to the research and development of generic drugs, natural products, and innovative therapeutic molecules. Operating under the BioCubaFarma business group, the center manages the entire pharmaceutical development cycle, including chemical synthesis, pharmaceutical technology, and clinical evaluation. CIDEM is a key supplier for the Cuban national health system, producing a wide range of essential medicines across various therapeutic areas such as neurology, oncology, and cardiovascular health. The center is notably recognized for its innovative pipeline in neurodegenerative diseases, particularly its work on neuroprotective agents like Amylovis. Additionally, CIDEM focuses on advanced drug delivery systems and the industrial scale-up of pharmaceutical formulations.